A Case Management Conference to discuss matters related to Stryker hip recall lawsuits was scheduled to take place today in New Jersey’s Bergen County Superior Court, according to a calendar posted on the litigation’s website.

There, parties may be likely to discuss updates in the consolidated proceeding’s mediation process, which began sessions for a number of cases on December 4th. An Order issued on November 18th indicates that parties were also ordered to meet and confer on the selection of claims for Phase II of the mediation process no later than December 16th. As of last month, a total of 553 lawsuits alleging injuries caused by the Stryker Rejuvenate and ABG II modular-neck hip stems had been filed in the proceeding. (In Re Stryker Rejuvenate Hip Stem and the ABG II Modular Hip Stem Litigation, No. 296)

Stryker Recall Suits Move Forward in U.S. Litigations

At the federal court level, 395 lawsuits that claim similar injuries caused by the metal-on-metal hip components are pending in a federal proceeding underway in the U.S. District Court, District of Minnesota. Several suits now pending in both litigations were filed by plaintiffs who say that revision surgery was necessary to correct the pain, swelling, metallosis and other adverse tissue reactions they may have experienced as a result of the implant, which was recalled on July 6, 2012 after Stryker Orthopaedics became aware of its potential to fret and corrode at the modular-neck junction. Following the Stryker recall, the company has advised on its website that all recipients undergo routine blood tests and cross-sectional imaging to monitor for elevated metal ion levels in the blood stream. This complication is caused by the shedding of metallic debris into the recipient’s body.

Following the ever-growing number of adverse event reports associated with metal implants similar to the Stryker Rejuvenate and ABG II hip stems, U.S. Food and Drug Administration has issued similar recommendations recently. In January 2013, the federal agency proposed new regulations that would redefine how this class of devices is approved for sale on the U.S. market. All manufacturers would be required to submit new products for rigorous testing in order to receive clearance, and produce clinical safety data on devices that have already been approved, in order to continue selling them.

File a Stryker Recall Lawsuit Today

Contact the lawyers at Bernstein Liebhard LLP today to start the process of filing a claim stemming from last year’s Stryker recall. Call the Firm at (877) 779-1414.

Published December 16, 2013 by